NCT03594422 - A Study of HQP1351 in Patients With GIST or Other Solid Tumors | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

July 11, 2018

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions

Gastrointestinal Stromal Tumor (GIST)Solid Tumor, Adult

Interventions

DRUG

HQP1351

HQP1351 Orally, once every other day (QOD) for consecutive 4 weeks each cycle.

Trial Locations (6)

RECRUITING

Union Hospital Tongji Medical College of Huazhong University of Science ang Technology, Wuhan

RECRUITING

Sun-Yat Sen University Cancer Center, Guangzhou

RECRUITING

Guangdong general hospital, Guangzhou

RECRUITING

Henan cancer hospital, Zhengzhou

RECRUITING

Chinese PLA general hospital, Beijing, China, Beijing

RECRUITING

Fudan University Shanghai Cancer Center, Shanghai